Abstract
Recent literature has explored the contributions of oligodendrocytes and myelin dysfunction to Alzheimer’s disease. Here, we discuss emerging evidence that oligodendrocytes may directly contribute to disease pathology and progression.
| Original language | English |
|---|---|
| Pages (from-to) | 1049-1051 |
| Number of pages | 3 |
| Journal | Nature Cell Biology |
| Volume | 27 |
| Issue number | 7 |
| DOIs |
|
| State | Published - Jul 2025 |